Deutsche Bank’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $77.1K | Hold |
7,424
| – | – | ﹤0.01% | 3331 |
|
2025
Q1 | $97.8K | Buy |
7,424
+3,786
| +104% | +$49.9K | ﹤0.01% | 3175 |
|
2024
Q4 | $65.2K | Hold |
3,638
| – | – | ﹤0.01% | 3334 |
|
2024
Q3 | $58.6K | Hold |
3,638
| – | – | ﹤0.01% | 3291 |
|
2024
Q2 | $98.3K | Buy |
3,638
+1,444
| +66% | +$39K | ﹤0.01% | 3076 |
|
2024
Q1 | $42.8K | Hold |
2,194
| – | – | ﹤0.01% | 3377 |
|
2023
Q4 | $45.4K | Hold |
2,194
| – | – | ﹤0.01% | 3382 |
|
2023
Q3 | $69.8K | Buy |
+2,194
| New | +$69.8K | ﹤0.01% | 3293 |
|
2022
Q4 | – | Sell |
-18,576
| Closed | -$914K | – | 3933 |
|
2022
Q3 | $914K | Buy |
18,576
+85
| +0.5% | +$4.18K | ﹤0.01% | 2022 |
|
2022
Q2 | $727K | Sell |
18,491
-7,129
| -28% | -$280K | ﹤0.01% | 2366 |
|
2022
Q1 | $946K | Sell |
25,620
-198
| -0.8% | -$7.31K | ﹤0.01% | 2374 |
|
2021
Q4 | $2.53M | Buy |
25,818
+5,827
| +29% | +$570K | ﹤0.01% | 1831 |
|
2021
Q3 | $2.5M | Sell |
19,991
-2,212
| -10% | -$276K | ﹤0.01% | 1924 |
|
2021
Q2 | $2.79M | Sell |
22,203
-3,335
| -13% | -$418K | ﹤0.01% | 1921 |
|
2021
Q1 | $3.47M | Buy |
25,538
+1,386
| +6% | +$188K | ﹤0.01% | 1783 |
|
2020
Q4 | $2.2M | Buy |
24,152
+22,944
| +1,899% | +$2.09M | ﹤0.01% | 1883 |
|
2020
Q3 | $90K | Buy |
1,208
+167
| +16% | +$12.4K | ﹤0.01% | 3545 |
|
2020
Q2 | $89K | Buy |
+1,041
| New | +$89K | ﹤0.01% | 3448 |
|
2020
Q1 | – | Sell |
-215
| Closed | -$15K | – | 4443 |
|
2019
Q4 | $15K | Sell |
215
-388
| -64% | -$27.1K | ﹤0.01% | 4199 |
|
2019
Q3 | $31K | Buy |
603
+309
| +105% | +$15.9K | ﹤0.01% | 4003 |
|
2019
Q2 | $15K | Sell |
294
-1,119
| -79% | -$57.1K | ﹤0.01% | 4529 |
|
2019
Q1 | $100K | Sell |
1,413
-2,824
| -67% | -$200K | ﹤0.01% | 4167 |
|
2018
Q4 | $337K | Buy |
4,237
+2,874
| +211% | +$229K | ﹤0.01% | 3513 |
|
2018
Q3 | $636K | Buy |
1,363
+196
| +17% | +$91.5K | ﹤0.01% | 3595 |
|
2018
Q2 | $463K | Buy |
1,167
+549
| +89% | +$218K | ﹤0.01% | 3819 |
|
2018
Q1 | $188K | Sell |
618
-441
| -42% | -$134K | ﹤0.01% | 4092 |
|
2017
Q4 | $311K | Sell |
1,059
-459
| -30% | -$135K | ﹤0.01% | 3701 |
|
2017
Q3 | $830K | Buy |
1,518
+1,072
| +240% | +$586K | ﹤0.01% | 3092 |
|
2017
Q2 | $264K | Buy |
446
+404
| +962% | +$239K | ﹤0.01% | 3657 |
|
2017
Q1 | $17K | Sell |
42
-66
| -61% | -$26.7K | ﹤0.01% | 4181 |
|
2016
Q4 | $54K | Buy |
+108
| New | +$54K | ﹤0.01% | 4060 |
|